Curis is a US-based drug development company, engaged in developing drug candidates for cancer treatment. The company operates in the US and China. The company's research and development programs include Erivedge, CA-170, CUDC-305, CUDC-427, CUDC-907, and IRAK4 inhibitor. Curis in collaboration with Genentech, developed Erivedge, an orally-administered Hedgehog pathway inhibitor, which is also referred to as vismodegib. The company is involved in developing CUDC-427 for solid tumor and lymphomas and CUDC-907 for lymphoma and multiple myeloma. Curis's network-targeted cancer program Debio 0932 (HSP90 inhibitor) is being developed by Debiopharm, a Switzerland-based pharmaceutical development company. The company in collaboration with Aurigene is involved in developing PD-L1 antagonist for cancers and IRAK4 inhibitor for hematological cancers, both of which are in preclinical stage. Curis' subsidiaries are Curis Securities Corporation, Curis Royalty and Curis Pharmaceuticals (Shanghai).
Scope of the Report
-- About the Company - Historical Details, Current Ownership Structure and basic overview of Curis, Inc. in terms of revenue, net income, and operating income.
-- Financials - Details about Curis, Inc. listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
-- Company SWOT Analysis - Outlines Curis, Inc.’s strengths, weaknesses, and opportunities and threats facing the company.
-- Recent Developments - Showcases Curis, Inc.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
-- Strategic Evaluation - Provides an overview of Curis, Inc.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.
Key Questions Answered
-- What domain does Curis, Inc. operate and what are key points about it?
-- What is the product / service portfolio of Curis, Inc.?
-- How has Curis, Inc. performed financially from the 2013?
-- How does Curis, Inc. rank among its peers in terms of revenue and market share?
-- What are Curis, Inc. strengths and weaknesses and what opportunities and threats does it face?
-- What are Curis, Inc.’s main growth strategies and how successful has the company been at implementing them?
-- What is the in-house technical capability of Curis, Inc.? Where does it procure / outsource it?
Reasons to buy
-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
-- 12 hour delivery time fulfilling your urgent requests as per your requirement
-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics
1. About the Company
1.1 History and Basic Facts
1.2 Ownership Structure and Key Executives
1.3 Head Office
1.4 Other Locations & Subsidiaries
1.5 List of Competitors
1.6 Employee Count & Distribution
2.1 Company Type (Listed / Unlisted)
2.2 Annual Statements
2.3 Key Financial Highlights
2.4 Region-wise Breakdown
3. Product / Services
4. SWOT Analysis
4.1 SWOT Overview
5. Recent Developments
5.1 Mergers & Acquisitions
5.2 Partnerships, Collaborations & Joint Ventures
5.3 New Product Launches
5.4 Business Expansion / Divestment
6. Strategic Evaluation
6.1 Corporate Strategy
6.2 Legal Issues
6.3 Analyst Outlook
7. Technology Landscape
-- 7.1.1 Industry Snapshot
-- 7.1.2 IT Spend
-- 7.1.3 Key Information Technology Trends
-- 7.2.1 IT Overview
-- 7.2.2 Key IT Technologies
-- 7.2.3 Recent IT Initiatives
-- 7.2.4 IT Outsourcing Engagements
-- 7.2.5 Key IT Management
-- 7.2.6 CIO/CTO Profile
-- About Us
-- Contact Us
Fig.1: Company Snapshot
Fig.2: Locations Listing on Map
Table.1: Ownership Structure
Table.2: List of Competitors
Table.3: Annual Statements
Table.4: Key Financial Highlights
Table.5: Region-wise Breakdown
Table.6: Product/Services Overview
Table.7: Mergers & Acquisitions
Table.8: Partnerships, Collaborations & Joint Ventures
Table.9: New Product Launches
Table.10: Business Expansion / Divestment
Table 11: IT Budgets
Table 12: Key IT Management (CIO / CTO)
Table 13: IT Deals undertaken in the past years